Mustang Bio, Inc.
MBIO
$1.16
-$0.04-3.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.81% | 90.71% | 97.05% | 88.95% | 85.98% |
| Total Depreciation and Amortization | -100.00% | -100.00% | -94.11% | -79.34% | -86.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.16% | -162.58% | -284.21% | 90.09% | 53.17% |
| Change in Net Operating Assets | -84.66% | -96.27% | -26.05% | -3,079.21% | 114.37% |
| Cash from Operations | 53.44% | 42.66% | 73.90% | 72.47% | 85.39% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 604.64% | -- | 15,442.86% | 26.47% | 300.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -41.63% | -- |
| Cash from Financing | 604.64% | -104.46% | 15,442.86% | 24.77% | 305.60% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 951.55% | -153.70% | 240.21% | 188.31% | 87.24% |